Efficacy and Safety of Head Acupuncture After Mechanical Thrombectomy for Acute Ischemic Stroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorXi'an No.3 Hospital
About this trial
To evaluate the efficacy and safety of head acupuncture combined with endovascular therapy for cerebral infarction compared with endovascular therapy alone
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥18 years;
Patients with acute ischemic stroke who received endovascular treatment within 24 hours of onset;
6 < NIHSS ≤25;
ASPECT score ≥6 points;
Disqualifiers
CT or brain MRI confirmed intracranial tumor and intracranial hemorrhage;
Contraindications of contrast media;
Dementia or mental illness，unable to cooperate with treatment and follow-up;
The expected survival time was less than 3 months;
Trial design
Design model
Parallel
Treatments tested in this trial
Scalp Acupuncture
Other interventionmplementation plan of head needle: The middle frontal line (MS1), the middle parietal line (MS5) and the back parietal and temporal oblique line (MS7) in the International Standardization Program for the Name of the first needle Point in 1989 were selected, and the needles were inserted along the shape of each section. One needle was inserted into the middle frontal line and the middle parietal line, and two needles were inserted into the back parietal and temporal oblique line. The KWD-808I pulse electrotherapy instrument produced by Changzhou Wujin Great Wall Medical Equipment Co., Ltd. is used on the needle handle after lifting, inserting and twisting. The continuous waveform was used, the voltage was 2-4 V, the frequency was 60-80 times /min, the intensity was tolerated by the patient, the needle was kept for 30min, and the treatment was performed once a day.
The treatment recommended in the guidelines for acute ischemic stroke was administered
Other interventionThe treatment recommended in the guidelines for acute ischemic stroke was administered
Treatment groups
272 Participants
are divided into 2 treatment groupsGroup A: experimental groupExperimental treatment 2 interventions
Group B: control groupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Ratio of Modified rankin scale (mRS) score ≤2
The modified rankin Scale (mRS) score ≤2 indicates that the patient has the ability to live independently.
Time frame
90 days after onsetSecondary outcomes
1
National Institute of Health stroke scale(NIHSS) score
NIHSS scores range from 0 to 42, with higher scores indicating more severe nerve damage.
Time frame
10 days after onset2
Modified rankin scale (mRS) score
Modified rankin scale (mRS) Score is used to measure the neurological function recovery status of patients after stroke, and its score ranges from 0 to 6
Time frame
90 days after onset3
Incidence of cerebral hemorrhage
No hemorrhage was found on the first head CT/MRI after cerebral infarction, but intracranial hemorrhage was found on the second head CT/MRI
Time frame
7 days after randomizationSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov